Search results
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 11 hours agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Male sexual enhancement supplements recalled as unapproved drugs
Consumer Affairs· 5 hours agoFDA analysis found these products to be tainted with sildenafil and Tadalafil. Sildenafil/Tadalafil...
FDA and DOJ pledge more cooperation on illegal e-cigarettes ahead of congressional hearing
Associated Press· 3 days agoPostal Service. The FDA has authorized a handful of e-cigarettes for adult smokers looking for...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance· 4 hours agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
A guide to safe US sunscreens – and the ingredients to avoid
The Guardian via Yahoo News· 23 hours agoWhile all sunscreen provides some amount of UV protection (broad-spectrum products provide the most)...
‘You’re failing!’: the federal government is having a reckoning over youth vaping, as senators tear...
Fortune via Yahoo Finance· 20 hours agoThom Tillis (R-N.C.) said during the hearing. Only 23 vape products are considered FDA approved and...
PureCycle’s recycled resin approved by FDA for food packaging
Packaging Gateway via Yahoo Finance· 1 day agoPureCycle prepared for submission to the FDA by using its Feedstock Evaluation Unit,...
Abbott Gets FDA Nod for Two Glucose Monitoring Systems - Abbott Laboratories (NYSE:ABT), Hims & Hers...
Benzinga· 60 minutes agoAbbott ABT announced that Lingo and Libre Rio, two of its glucose monitoring system, have received ...
Why FDA Panel Rejected MDMA Therapy—And What’s Next For Psychedelic Medicine
Forbes· 13 hours agoThe FDA has previously acknowledged its therapeutic potential, granting a new drug application,...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
Zacks via Yahoo Finance· 8 hours agoBiogen/Eisai’s controversial medicine, Aduhelm, was approved by the FDA in 2021. However, in January...